Zobrazeno 1 - 10
of 59
pro vyhledávání: '"You-Yong Lu"'
Autor:
Chang Liu, Kaiyi Li, Xizhao Sui, Tian Zhao, Ting Zhang, Zhongyao Chen, Hainan Wu, Chao Li, Hao Li, Fan Yang, Zhidong Liu, You‐Yong Lu, Jun Wang, Xiaofang Chen, Peng Liu
Publikováno v:
Advanced Science, Vol 11, Iss 31, Pp n/a-n/a (2024)
Abstract In vitro models coupled with multimodal approaches are needed to dissect the dynamic response of local tumor immune microenvironment (TIME) to immunotherapy. Here the patient‐derived primary lung cancer organoids (pLCOs) are generated by i
Externí odkaz:
https://doaj.org/article/5945f0f39c7b4042b1677a2f7015ba45
Publikováno v:
Iranian Journal of Medical Sciences, Vol 48, Iss 4, Pp 401-413 (2023)
Background: Pancreatic cancer is a malignancy with high mortality due to the difficulties in early detection. We investigated and compared the diagnostic and prognostic performance of several blood biomarkers, including microRNA-25 (miR-25), carbohyd
Externí odkaz:
https://doaj.org/article/b0f5a288e44c41f88e1150312c34ad56
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
ObjectiveTo evaluate the clinical efficacy and safety of hydrogen inhalation in improving hearing loss in patients with long-term survival of nasopharyngeal carcinoma after radiotherapy.MethodsThe eustachian tube dysfunction score, pure tone air cond
Externí odkaz:
https://doaj.org/article/e54439f859c3491c9adbaa38545559eb
Autor:
Yun Cui, Wen-Yu Su, Jing Xing, Ying-Chao Wang, Ping Wang, Xiao-Yu Chen, Zhi-Yong Shen, Hui Cao, You-Yong Lu, Jing-Yuan Fang
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e25872 (2011)
As a newly identified and characterized gene, p42.3 is associated with cell proliferation and tumorigenicity. The expression of p42.3 is upregulated in human gastric cancer (GC), but its underlying mechanisms of action are not well understood. MicroR
Externí odkaz:
https://doaj.org/article/f1a9974027004f1882d879b6359c878e
Autor:
You-Yong Lu, Pai-Li Geng, Hai-Hong Zhu, Bai Xiao, Xiao-Ting Hu, Qing-Yun Zhang, Wen-Mei Li, Hua Deng, Yan-Hong Yang
Purpose: Prognostic markers discovery is a strategy for early diagnosis and individualization therapy for human cancer. In this study, we focus to integrate different methods to identify specific biomarker and elucidate its clinical significance.Expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c60bb523f26ec902bb5a7df9da2626e
https://doi.org/10.1158/1078-0432.c.6518560
https://doi.org/10.1158/1078-0432.c.6518560
Autor:
You-Yong Lu, Pai-Li Geng, Hai-Hong Zhu, Bai Xiao, Xiao-Ting Hu, Qing-Yun Zhang, Wen-Mei Li, Hua Deng, Yan-Hong Yang
Supplementary Data from Identification of Matrix Metalloproteinase 11 as a Predictive Tumor Marker in Serum Based on Gene Expression Profiling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6cae55e291fae9bda0a37ece61d88d
https://doi.org/10.1158/1078-0432.22441519
https://doi.org/10.1158/1078-0432.22441519
Publikováno v:
Medical Gas Research
Following standard treatments, the traditional model for enhancing anti-tumor immunity involves performing immune reconstitution (e.g., adoptive immune cell therapies or immunoenhancing drugs) to prevent recurrence. For patients with advanced non-sma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc05dd4d0c748614fe948bda1ea976d
http://europepmc.org/articles/PMC8092147
http://europepmc.org/articles/PMC8092147
Publikováno v:
Medical Gas Research
The use of hydrogen for cancer control has made great progress in cytology and animal experiments. With the increasing number of hydrogen products on the market, larger numbers of advanced cancer patients have participated in clinical trials or recei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266476957ba66d155076c356915bf9da
https://doi.org/10.4103/2045-9912.296044
https://doi.org/10.4103/2045-9912.296044
Publikováno v:
Medical Gas Research
Chemotherapy, targeted therapy, and immunotherapy are used against advanced non-small cell lung cancer. A clinically efficacious method for relieving the adverse events associated of such therapies is lacking. Fifty-eight adult patients were enrolled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a95f689fbf265ee646e511f598c524db
https://doi.org/10.4103/2045-9912.285560
https://doi.org/10.4103/2045-9912.285560
Autor:
Pan, Yuan-Ming, Wang, Cheng-Gang, Zhu, Min, Xing, Rui, Cui, Jian-Tao, Li, Wen-Mei, Yu, De-Dong, Wang, Shu-Bin, Zhu, Wei, Ying-Jiang Ye, Wu, Yun, Wang, Shan, You-Yong Lu
Oligonucleotide primers for STAT3, EZH2, β-actin, reporter gene, EMSA, and siRNA of STAT3. Table S2. Correlation between STAT3 and EZH2 expression in GC. Table S3. STAT3 and EZH2 were associated with the clinical stage of the malignancy. Table S4. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60b013f91e4233792ad15eafc31750a1